aTyr Pharma, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx |
|---|---|---|---|
| FY2021 | $-33.1M | $-33.3M | $192.0K |
| FY2022 | $-41.9M | $-43.5M | $1.6M |
| FY2023 | $-33.2M | $-37.4M | $4.2M |
| FY2024 | $-69.1M | $-69.2M | $65.0K |
| FY2025 | $-62.0M | $-62.1M | $77.0K |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx |
|---|---|---|---|
| FY2021 | $-33.1M | $-33.3M | $192.0K |
| FY2022 | $-41.9M | $-43.5M | $1.6M |
| FY2023 | $-33.2M | $-37.4M | $4.2M |
| FY2024 | $-69.1M | $-69.2M | $65.0K |
| FY2025 | $-62.0M | $-62.1M | $77.0K |